<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p31" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_31{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_31{left:341px;bottom:30px;}
#t3_31{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_31{left:377px;bottom:30px;}
#t5_31{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_31{left:540px;bottom:30px;}
#t7_31{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_31{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_31{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_31{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_31{left:285px;bottom:827px;letter-spacing:-0.26px;}
#tc_31{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_31{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_31{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_31{left:1109px;bottom:28px;letter-spacing:0.29px;}
#tg_31{left:1067px;bottom:423px;letter-spacing:-0.1px;}
#th_31{left:1067px;bottom:405px;letter-spacing:-0.09px;}
#ti_31{left:1067px;bottom:386px;letter-spacing:-0.08px;}
#tj_31{left:1074px;bottom:346px;letter-spacing:-0.09px;}
#tk_31{left:1074px;bottom:328px;letter-spacing:-0.06px;}
#tl_31{left:1074px;bottom:310px;letter-spacing:-0.08px;}
#tm_31{left:1074px;bottom:291px;letter-spacing:-0.09px;}
#tn_31{left:1074px;bottom:273px;letter-spacing:-0.25px;}
#to_31{left:159px;bottom:778px;letter-spacing:0.44px;word-spacing:-0.9px;}
#tp_31{left:776px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tq_31{left:161px;bottom:707px;letter-spacing:-0.09px;}
#tr_31{left:161px;bottom:689px;letter-spacing:-0.09px;}
#ts_31{left:161px;bottom:671px;letter-spacing:-0.08px;}
#tt_31{left:161px;bottom:652px;letter-spacing:-0.1px;}
#tu_31{left:161px;bottom:634px;letter-spacing:-0.09px;}
#tv_31{left:161px;bottom:616px;letter-spacing:-0.11px;}
#tw_31{left:36px;bottom:573px;letter-spacing:-0.1px;}
#tx_31{left:36px;bottom:555px;letter-spacing:-0.07px;}
#ty_31{left:36px;bottom:536px;letter-spacing:-0.09px;}
#tz_31{left:36px;bottom:518px;letter-spacing:-0.12px;}
#t10_31{left:36px;bottom:500px;letter-spacing:-0.1px;}
#t11_31{left:97px;bottom:507px;letter-spacing:-0.09px;}
#t12_31{left:36px;bottom:481px;letter-spacing:-0.08px;}
#t13_31{left:36px;bottom:463px;letter-spacing:-0.12px;}
#t14_31{left:76px;bottom:471px;}
#t15_31{left:161px;bottom:380px;letter-spacing:-0.08px;}
#t16_31{left:161px;bottom:362px;letter-spacing:-0.11px;}
#t17_31{left:305px;bottom:698px;letter-spacing:-0.13px;}
#t18_31{left:327px;bottom:706px;}
#t19_31{left:305px;bottom:680px;letter-spacing:-0.06px;}
#t1a_31{left:305px;bottom:661px;letter-spacing:-0.09px;}
#t1b_31{left:305px;bottom:643px;letter-spacing:-0.09px;}
#t1c_31{left:305px;bottom:625px;letter-spacing:-0.11px;}
#t1d_31{left:393px;bottom:632px;letter-spacing:-0.13px;}
#t1e_31{left:305px;bottom:436px;letter-spacing:-0.09px;}
#t1f_31{left:305px;bottom:417px;letter-spacing:-0.09px;}
#t1g_31{left:305px;bottom:399px;letter-spacing:-0.1px;}
#t1h_31{left:388px;bottom:407px;}
#t1i_31{left:305px;bottom:381px;letter-spacing:-0.09px;}
#t1j_31{left:305px;bottom:328px;letter-spacing:-0.1px;}
#t1k_31{left:305px;bottom:285px;letter-spacing:-0.09px;}
#t1l_31{left:305px;bottom:266px;letter-spacing:-0.1px;word-spacing:-0.08px;}
#t1m_31{left:441px;bottom:466px;letter-spacing:-0.1px;}
#t1n_31{left:441px;bottom:448px;letter-spacing:-0.09px;}
#t1o_31{left:441px;bottom:430px;letter-spacing:-0.09px;}
#t1p_31{left:506px;bottom:437px;}
#t1q_31{left:431px;bottom:361px;letter-spacing:-0.1px;}
#t1r_31{left:431px;bottom:343px;letter-spacing:-0.09px;}
#t1s_31{left:431px;bottom:325px;letter-spacing:-0.09px;}
#t1t_31{left:497px;bottom:332px;}
#t1u_31{left:558px;bottom:410px;letter-spacing:-0.09px;}
#t1v_31{left:558px;bottom:392px;letter-spacing:-0.09px;word-spacing:-0.26px;}
#t1w_31{left:558px;bottom:374px;letter-spacing:-0.1px;}
#t1x_31{left:558px;bottom:324px;letter-spacing:-0.08px;}
#t1y_31{left:558px;bottom:306px;letter-spacing:-0.09px;}
#t1z_31{left:737px;bottom:447px;letter-spacing:-0.13px;}
#t20_31{left:761px;bottom:454px;}
#t21_31{left:732px;bottom:390px;letter-spacing:-0.1px;}
#t22_31{left:900px;bottom:398px;letter-spacing:-0.09px;}
#t23_31{left:924px;bottom:390px;letter-spacing:-0.09px;}
#t24_31{left:735px;bottom:335px;letter-spacing:-0.13px;}
#t25_31{left:758px;bottom:342px;}
#t26_31{left:735px;bottom:316px;letter-spacing:-0.06px;}
#t27_31{left:735px;bottom:298px;letter-spacing:-0.1px;}
#t28_31{left:978px;bottom:305px;letter-spacing:-0.12px;}
#t29_31{left:1071px;bottom:652px;letter-spacing:-0.09px;}
#t2a_31{left:1071px;bottom:634px;letter-spacing:-0.06px;}
#t2b_31{left:1071px;bottom:616px;letter-spacing:-0.08px;}
#t2c_31{left:1071px;bottom:597px;letter-spacing:-0.09px;}
#t2d_31{left:1071px;bottom:579px;letter-spacing:-0.25px;}
#t2e_31{left:158px;bottom:555px;letter-spacing:-0.09px;}
#t2f_31{left:158px;bottom:536px;letter-spacing:-0.09px;}
#t2g_31{left:158px;bottom:518px;letter-spacing:-0.09px;}
#t2h_31{left:158px;bottom:500px;letter-spacing:-0.09px;}
#t2i_31{left:158px;bottom:481px;letter-spacing:-0.09px;}
#t2j_31{left:302px;bottom:575px;letter-spacing:-0.09px;}
#t2k_31{left:302px;bottom:557px;letter-spacing:-0.1px;}
#t2l_31{left:391px;bottom:564px;letter-spacing:-0.12px;}
#t2m_31{left:302px;bottom:520px;letter-spacing:-0.1px;}
#t2n_31{left:302px;bottom:484px;letter-spacing:-0.1px;}
#t2o_31{left:366px;bottom:491px;}
#t2p_31{left:567px;bottom:148px;}
#t2q_31{left:577px;bottom:142px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t2r_31{left:1087px;bottom:142px;}
#t2s_31{left:567px;bottom:131px;}
#t2t_31{left:573px;bottom:125px;letter-spacing:0.12px;}
#t2u_31{left:567px;bottom:114px;}
#t2v_31{left:577px;bottom:108px;letter-spacing:0.12px;}
#t2w_31{left:609px;bottom:108px;letter-spacing:0.12px;}
#t2x_31{left:687px;bottom:108px;letter-spacing:0.08px;word-spacing:0.05px;}
#t2y_31{left:36px;bottom:181px;}
#t2z_31{left:46px;bottom:176px;letter-spacing:0.13px;word-spacing:-0.06px;}
#t30_31{left:331px;bottom:176px;}
#t31_31{left:36px;bottom:165px;}
#t32_31{left:42px;bottom:159px;letter-spacing:0.13px;}
#t33_31{left:257px;bottom:159px;}
#t34_31{left:36px;bottom:148px;}
#t35_31{left:42px;bottom:142px;letter-spacing:0.12px;}
#t36_31{left:45px;bottom:125px;letter-spacing:0.11px;word-spacing:0.02px;}
#t37_31{left:45px;bottom:108px;letter-spacing:0.12px;}
#t38_31{left:394px;bottom:108px;letter-spacing:0.13px;}
#t39_31{left:478px;bottom:108px;}
#t3a_31{left:471px;bottom:272px;letter-spacing:-0.35px;}
#t3b_31{left:558px;bottom:623px;letter-spacing:-0.1px;}
#t3c_31{left:558px;bottom:603px;letter-spacing:-0.09px;}
#t3d_31{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_31{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_31{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_31{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_31{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_31{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_31{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_31{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s7_31{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s8_31{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s9_31{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sa_31{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sb_31{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sc_31{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts31" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg31Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg31" style="-webkit-user-select: none;"><object width="1210" height="935" data="31/31.svg" type="image/svg+xml" id="pdf31" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_31" class="t s0_31">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_31" class="t s1_31">® </span>
<span id="t3_31" class="t s0_31">(NCCN </span>
<span id="t4_31" class="t s1_31">® </span>
<span id="t5_31" class="t s0_31">), All rights reserved. NCCN Guidelines </span>
<span id="t6_31" class="t s1_31">® </span>
<span id="t7_31" class="t s0_31">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_31" class="t s2_31">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_31" class="t s2_31">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_31" class="t s3_31">NCCN Guidelines Version 4.2024 </span>
<span id="tb_31" class="t s3_31">Cancer of the Hypopharynx </span>
<span id="tc_31" class="t s4_31">NCCN Guidelines Index </span>
<span id="td_31" class="t s4_31">Table of Contents </span>
<span id="te_31" class="t s4_31">Discussion </span>
<span id="tf_31" class="t s5_31">HYPO-6 </span>
<span id="tg_31" class="t s5_31">Follow-up </span>
<span id="th_31" class="t s6_31">(FOLL-A, 1 </span>
<span id="ti_31" class="t s6_31">of 2) </span>
<span id="tj_31" class="t s5_31">Recurrent </span>
<span id="tk_31" class="t s5_31">or </span>
<span id="tl_31" class="t s5_31">persistent </span>
<span id="tm_31" class="t s5_31">disease </span>
<span id="tn_31" class="t s6_31">(ADV-3) </span>
<span id="to_31" class="t s5_31">RESPONSE ASSESSMENT </span><span id="tp_31" class="t s5_31">ADJUVANT TREATMENT </span>
<span id="tq_31" class="t s5_31">Primary </span>
<span id="tr_31" class="t s5_31">site: CR and </span>
<span id="ts_31" class="t s5_31">stable or </span>
<span id="tt_31" class="t s5_31">improved </span>
<span id="tu_31" class="t s5_31">disease in </span>
<span id="tv_31" class="t s5_31">neck </span>
<span id="tw_31" class="t s5_31">Response </span>
<span id="tx_31" class="t s5_31">after </span>
<span id="ty_31" class="t s5_31">induction </span>
<span id="tz_31" class="t s5_31">chemo- </span>
<span id="t10_31" class="t s5_31">therapy </span>
<span id="t11_31" class="t s7_31">k,l </span>
<span id="t12_31" class="t s5_31">for T4a, </span>
<span id="t13_31" class="t s5_31">N0–3 </span>
<span id="t14_31" class="t s7_31">n </span>
<span id="t15_31" class="t s5_31">Primary site: </span>
<span id="t16_31" class="t s5_31">&lt; PR </span>
<span id="t17_31" class="t s5_31">RT </span>
<span id="t18_31" class="t s7_31">h </span>
<span id="t19_31" class="t s5_31">or </span>
<span id="t1a_31" class="t s5_31">Consider </span>
<span id="t1b_31" class="t s5_31">systemic </span>
<span id="t1c_31" class="t s5_31">therapy/RT </span>
<span id="t1d_31" class="t s7_31">h,k </span>
<span id="t1e_31" class="t s5_31">Surgery </span>
<span id="t1f_31" class="t s5_31">+ neck </span>
<span id="t1g_31" class="t s5_31">dissection </span>
<span id="t1h_31" class="t s7_31">i </span>
<span id="t1i_31" class="t s5_31">as indicated </span>
<span id="t1j_31" class="t s5_31">or </span>
<span id="t1k_31" class="t s5_31">Unresectable </span>
<span id="t1l_31" class="t s5_31">nodal disease </span>
<span id="t1m_31" class="t s5_31">No adverse </span>
<span id="t1n_31" class="t s5_31">pathologic </span>
<span id="t1o_31" class="t s5_31">features </span>
<span id="t1p_31" class="t s7_31">j </span>
<span id="t1q_31" class="t s5_31">Adverse </span>
<span id="t1r_31" class="t s5_31">pathologic </span>
<span id="t1s_31" class="t s5_31">features </span>
<span id="t1t_31" class="t s7_31">j </span>
<span id="t1u_31" class="t s5_31">Extranodal </span>
<span id="t1v_31" class="t s5_31">extension and/or </span>
<span id="t1w_31" class="t s5_31">positive margin </span>
<span id="t1x_31" class="t s5_31">Other risk </span>
<span id="t1y_31" class="t s5_31">features </span>
<span id="t1z_31" class="t s5_31">RT </span>
<span id="t20_31" class="t s7_31">h </span>
<span id="t21_31" class="t s5_31">Systemic therapy/RT </span>
<span id="t22_31" class="t s7_31">h,k </span>
<span id="t23_31" class="t s5_31">(category 1) </span>
<span id="t24_31" class="t s5_31">RT </span>
<span id="t25_31" class="t s7_31">h </span>
<span id="t26_31" class="t s5_31">or </span>
<span id="t27_31" class="t s5_31">Consider systemic therapy/RT </span>
<span id="t28_31" class="t s7_31">h,k </span>
<span id="t29_31" class="t s5_31">Recurrent </span>
<span id="t2a_31" class="t s5_31">or </span>
<span id="t2b_31" class="t s5_31">persistent </span>
<span id="t2c_31" class="t s5_31">disease </span>
<span id="t2d_31" class="t s6_31">(ADV-3) </span>
<span id="t2e_31" class="t s5_31">Primary site: </span>
<span id="t2f_31" class="t s5_31">PR and stable </span>
<span id="t2g_31" class="t s5_31">or improved </span>
<span id="t2h_31" class="t s5_31">disease in </span>
<span id="t2i_31" class="t s5_31">neck </span>
<span id="t2j_31" class="t s5_31">Systemic </span>
<span id="t2k_31" class="t s5_31">therapy/RT </span>
<span id="t2l_31" class="t s7_31">h,k </span>
<span id="t2m_31" class="t s5_31">or </span>
<span id="t2n_31" class="t s5_31">Surgery </span>
<span id="t2o_31" class="t s7_31">i </span>
<span id="t2p_31" class="t s8_31">k </span>
<span id="t2q_31" class="t s9_31">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2r_31" class="t sa_31">. </span>
<span id="t2s_31" class="t s8_31">l </span>
<span id="t2t_31" class="t sb_31">In randomized clinical trials, assessment of response has been done after 2 or 3 cycles. </span>
<span id="t2u_31" class="t s8_31">n </span>
<span id="t2v_31" class="t sa_31">See </span><span id="t2w_31" class="t s9_31">Discussion </span><span id="t2x_31" class="t sa_31">on induction chemotherapy. </span>
<span id="t2y_31" class="t s8_31">h </span>
<span id="t2z_31" class="t s9_31">Principles of Radiation Therapy (HYPO-A)</span><span id="t30_31" class="t sa_31">. </span>
<span id="t31_31" class="t s8_31">i </span>
<span id="t32_31" class="t s9_31">Principles of Surgery (SURG-A)</span><span id="t33_31" class="t sa_31">. </span>
<span id="t34_31" class="t s8_31">j </span>
<span id="t35_31" class="t sa_31">Adverse pathologic features: extranodal extension, positive margins, </span>
<span id="t36_31" class="t sa_31">close margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, perineural </span>
<span id="t37_31" class="t sa_31">invasion, vascular invasion, and lymphatic invasion </span><span id="t38_31" class="t s9_31">(Discussion)</span><span id="t39_31" class="t sa_31">. </span>
<span id="t3a_31" class="t s6_31">ADV-1 </span>
<span id="t3b_31" class="t s6_31">Post Systemic Therapy/RT or RT </span>
<span id="t3c_31" class="t s6_31">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t3d_31" class="t sc_31">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
